Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 465
Immune Disorders Drugs 196
Cardiovascular Drugs 154
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Endocrine and Metabolic Disorders Drugs 103
Drug Discovery 102
Musculoskeletal Disorders Drugs 94
Clinical Trials 90
Pharmaceuticals 88
Leukemia Drugs 83
Hematological Drugs 83
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Infusions and Injectables 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Antibiotics 23
Kidney Cancer Drugs 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Uterine Cancer Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

2,387 Results (Page 90 of 120)
- Relevance
  Sort by

Thalidomide Analogue Market - Global Forecast 2025-2030

 Report
August 2025
190 Pages
Global

From

€3168EUR$3,545USD£2,708GBP

€3520EUR$3,939USD£3,009GBP

Autologous CAR-T Cell Therapy Market - Global Forecast 2025-2030

 Report
August 2025
199 Pages
Global

From

€3168EUR$3,545USD£2,708GBP

€3520EUR$3,939USD£3,009GBP

Azacitidine Drug Market - Global Forecast 2025-2030

 Report
August 2025
190 Pages
Global

From

€3168EUR$3,545USD£2,708GBP

€3520EUR$3,939USD£3,009GBP

Urethral Cancer Treatment Market - Global Forecast 2025-2030

 Report
August 2025
196 Pages
Global

From

€3168EUR$3,545USD£2,708GBP

€3520EUR$3,939USD£3,009GBP

Immune Checkpoint Proteins Market - Global Forecast 2025-2030

 Report
August 2025
199 Pages
Global

From

€3168EUR$3,545USD£2,708GBP

€3520EUR$3,939USD£3,009GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Molecular Oncology Market - Global Forecast 2025-2030

 Report
August 2025
186 Pages
Global

From

€3168EUR$3,545USD£2,708GBP

€3520EUR$3,939USD£3,009GBP

VEGFR-2 Inhibitor Market - Global Forecast 2025-2030

 Report
August 2025
195 Pages
Global

From

€3168EUR$3,545USD£2,708GBP

€3520EUR$3,939USD£3,009GBP

Pediatric Oncology Treatment Market - Global Forecast 2025-2030

 Report
August 2025
182 Pages
Global

From

€3168EUR$3,545USD£2,708GBP

€3520EUR$3,939USD£3,009GBP

Anti-Inflammatory Therapeutics Market 2024-2028

 Report
May 2024
174 Pages
Global

From

€2234EUR$2,500USD£1,910GBP

Targeted Cancer Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

 Report
May 2026
188 Pages
Global

From

€4022EUR$4,500USD£3,437GBP

Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry Perspective

 Report
August 2023
267 Pages
Global

From

€2150EUR$2,577USD£1,902GBP

Intravitreal (IVT) Injectable Industry Analysis, Size, Share, Growth, Trends, and Forecast 2026-2033 - (by Drug Class, Indication, Geographic Coverage and by Company)

 Report
March 2026
214 Pages
Global

From

€4464EUR$4,995USD£3,815GBP

Rare Disease Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
130 Pages
Global

From

€3500EUR$4,195USD£3,096GBP

Polymyalgia Rheumatica - Pipeline Insight, 2025

 Drug Pipelines
April 2025
60 Pages
Global

From

€1117EUR$1,250USD£955GBP

Scientific Research and Development Services Market Report 2026

 Report
January 2026
250 Pages
Global

From

€4013EUR$4,490USD£3,430GBP

Orphan Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4013EUR$4,490USD£3,430GBP

Metastatic Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

 Report
May 2026
182 Pages
Global

From

€4022EUR$4,500USD£3,437GBP

Head and Neck Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

 Report
May 2026
180 Pages
Global

From

€4022EUR$4,500USD£3,437GBP

Antibody Fragments Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

 Report
May 2026
185 Pages
Global

From

€4022EUR$4,500USD£3,437GBP

Drug Formulation Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4013EUR$4,490USD£3,430GBP

2,387 Results (Page 90 of 120)
- 1
- 88
- 89
- 90
- 91
- 92

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.